- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05191693
Long-term Outcomes of Endoscopic Papillary Balloon Dilation for 8-12mm Bile Duct Stones: a Prospective Study
The investigators prospectively evaluated long-term outcomes of ELBPD+EST for CBD stones up to 8-12mm.
EPBD+EST in patients with CBD stones up to 8-12mm appears to be associated with a very low (<3%) rate of long-term stone recurrence. The efficacy of EPBD for 8-12mm stones warrants further exploration in randomized trials.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Consecutive patients with CBD stones up to 8-12mm successfully treated by EPBD+EST from September 2018 to August 2020 were prospectively followed for at least 12 months. CBD stone recurrence was defined as recurrent stones confirmed by ERCP during the follow-up period. The maximum diameter of the balloon used was 15mm.
Overall, 72 patients (mean age: 67 years, 52.8% males) were included, of whom 22 (30.5%) had multiple CBD stones, 23 (31.9%) had a history of cholecystectomy, 13 (18.1%) had a periampullary diverticulum and 22 (30.5%) had a previous EST. The mean CBD diameter was 11.6±1mm, whereas a tapered duct was noted in 7 (9.7%). Post-procedural bleeding occurred in one case, treated successfully a with a fully covered metal stent. Mild cholangitis occurred in two cases. No cases with perforation or PEP were observed. During a mean follow-up of 22.4±6.2 months (range 13-36), CBD stones recurred in 2/72 (2.7%).
EPBD+EST in patients with CBD stones up to 8-12mm appears to be associated with a very low (<3%) rate of long-term stone recurrence. The efficacy of EPBD for 8-12mm stones warrants further exploration in randomized trials.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Heraklion, Hellas, 71409
- ''Benizelion" General Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:patients with ELBPD+EST for CBD stones up to 8-12mm from September 2018 to August 2020 -
Exclusion Criteria: Patients with bile duct stones less than 8mm or more than 12mm.
-
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: Kohort
- Tidsperspektiver: Retrospektiv
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
patients with CBD stones up to 8-12mm
72 patients (mean age: 67 years, 52.8% males) were included, of whom 22 (30.5%) had multiple CBD stones, 23 (31.9%) had a history of cholecystectomy, 13 (18.1%)
had a periampullary diverticulum and 22 (30.5%) had a previous EST
|
endoscopic papillary balloon dilation (EPBD) with endoscopic sphincterotomy (EST
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Stone recurrence after endoscopic papillary balloon dilation (EPBD) with endoscopic sphincterotomy (EST) in prior ERCP.
Tidsramme: 22.4±6.2 months
|
Patients with CBD stones up to 8-12mm successfully treated by EPBD+EST from September 2018 to August 2020 were prospectively followed for at least 12 months.
CBD stone recurrence was defined as recurrent stones confirmed by ERCP during the follow-up period.
The maximum diameter of the balloon used was 15mm.
|
22.4±6.2 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studieleder: Gregorios Gregorios, Director, ''Benizelion" General Hospital, Heraklion, Crete
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Paspatis-balloon dilation
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på ERCP
-
First People's Hospital of HangzhouFullførtCholedocholithiasis | Vanlige gallegangsberegningerKina
-
McGill University Health Centre/Research Institute...Unity Health Toronto; Jewish General HospitalRekruttering
-
Minia UniversityFullførtGallestein komplisert av CBD-steinerEgypt
-
Beijing Friendship HospitalRekrutteringCholedocholithiasis med akutt kolangittKina
-
Weill Medical College of Cornell UniversityUkjentBukspyttkjertelkreft | Kolangiokarsinom | Galleveiskreft | Kronisk pankreatitt | Biliær striktur | Biliær obstruksjon | Ampulær kreft | Stentobstruksjon | Proksimal kanalfortrengning | Distal kanalforstrengning | Biliær sphincter stenose | Påvirkede steiner | Peri-ampullære divertikler | Endret anatomiForente stater, Brasil
-
Beijing Friendship HospitalRekrutteringCholedocholithiasis med akutt kolangittKina
-
Mansoura UniversityFullført
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)FullførtSphincter of Oddi DysfunctionForente stater
-
Azienda Ospedaliera San PaoloFullførtKomplikasjoner ved kirurgisk og medisinsk behandling: Generelle vilkår
-
University of FloridaFullførtGallekanalfornemmelse | Nøyaktighet av vevsdiagnose | Bukspyttkjertelen duct fortrengningForente stater